药品注册申请号:062831
申请类型:ANDA (仿制药申请)
申请人:SANDOZ
申请人全名:SANDOZ INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 500MG BASE/VIAL No No AP 1988/12/09 1988/12/09 Prescription
002 CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 1GM BASE/VIAL No No AP 1988/12/09 Prescription
003 CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 10GM BASE/VIAL No No AP 1992/09/25 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2016/06/24 SUPPL-38(补充) Approval Labeling STANDARD
2016/06/24 SUPPL-33(补充) Approval Labeling STANDARD
2013/01/15 SUPPL-29(补充) Approval Labeling
2008/02/12 SUPPL-18(补充) Approval Labeling
2006/06/01 SUPPL-15(补充) Approval Labeling
1999/03/05 SUPPL-9(补充) Approval Manufacturing (CMC)
1998/11/25 SUPPL-8(补充) Approval Labeling
1998/11/25 SUPPL-7(补充) Approval Manufacturing (CMC)
1995/05/16 SUPPL-6(补充) Approval Labeling
1992/12/15 SUPPL-2(补充) Approval Manufacturing (CMC)
1992/12/15 SUPPL-1(补充) Approval Labeling
1992/09/25 SUPPL-5(补充) Approval Labeling
1991/11/18 SUPPL-3(补充) Approval Labeling
1990/07/17 SUPPL-4(补充) Approval Manufacturing (CMC)
1988/12/09 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:CEFAZOLIN SODIUM 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 500MG BASE/VIAL 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
062831 001 ANDA CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 500MG BASE/VIAL Prescription No No AP 1988/12/09 SANDOZ
065047 001 ANDA CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 500MG BASE/VIAL Prescription No Yes AP 2001/09/18 HIKMA FARMACEUTICA
065303 001 ANDA CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 500MG BASE/VIAL Prescription No No AP 2008/10/22 ACS DOBFAR
活性成分:CEFAZOLIN SODIUM 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 1GM BASE/VIAL 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
062831 002 ANDA CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 1GM BASE/VIAL Prescription No No AP 1988/12/09 SANDOZ
065047 002 ANDA CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 1GM BASE/VIAL Prescription No Yes AP 2001/09/18 HIKMA FARMACEUTICA
065345 001 ANDA CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 1GM BASE/VIAL Prescription No No AP 2007/05/09 SANDOZ
065303 002 ANDA CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 1GM BASE/VIAL Prescription No No AP 2008/10/22 ACS DOBFAR
203661 001 ANDA CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 1GM BASE/VIAL Prescription No No AP 2015/12/28 QILU
活性成分:CEFAZOLIN SODIUM 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 10GM BASE/VIAL 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
062831 003 ANDA CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 10GM BASE/VIAL Prescription No No AP 1992/09/25 SANDOZ
065143 001 ANDA CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 10GM BASE/VIAL Prescription No No AP 2004/10/18 HIKMA FARMACEUTICA
065306 001 ANDA CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 10GM BASE/VIAL Prescription No No AP 2008/10/22 ACS DOBFAR
209217 001 ANDA CEFAZOLIN SODIUM CEFAZOLIN SODIUM INJECTABLE;INJECTION EQ 10GM BASE/VIAL Prescription No Yes AP 2018/10/17 QILU
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database